Press release
Competitive Landscape: Leading Companies and New Entrants in the Radiopharmaceuticals Market
Radiopharmaceuticals Market
Radiopharmaceuticals Market Size Forecast Through 2030
The market for radiopharmaceuticals is poised for significant expansion, projected to reach $13.68 billion by 2030. This growth corresponds to a strong compound annual growth rate (CAGR) of 13.5%. Factors propelling this increase include advancements in precision oncology, a rising need for targeted radiotherapies, a growing number of diagnostic imaging centers, increased investments in cyclotron facilities, and technological progress in isotope production. Throughout the forecast period, notable trends expected to shape the market include heightened use of radiopharmaceuticals in cancer treatment, the rise of theranostics applications, expansion in PET and SPECT imaging, ongoing development of targeted therapies, and improved infrastructure supporting nuclear medicine.
Download a free sample of the radiopharmaceuticals market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3471&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Key Industry Leaders Driving the Radiopharmaceuticals Sector
Several prominent companies are at the forefront of the radiopharmaceuticals market, including Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, and many others. These organizations are shaping the landscape through innovation, extensive production capabilities, and strategic developments worldwide.
Strategic Acquisition Expands Radiopharmaceuticals Capabilities
In a significant move in January 2024, Eli Lilly, a US-based pharmaceutical giant, completed the acquisition of Point Biopharma for roughly $1.4 billion. This deal strengthens Lilly's position in radioligand therapies-a growing class of cancer treatments that combine radiation with targeted delivery. Point Biopharma, specializing in developing targeted radioligand therapies for various cancers, complements Lilly's existing oncology portfolio and is expected to advance patient treatment outcomes significantly.
View the full radiopharmaceuticals market report:
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Strategic Collaborations Accelerate Market Growth
The radiopharmaceuticals market is also benefiting from increased collaboration among industry stakeholders. Companies are forming alliances to speed up innovation, expand manufacturing capacity, and improve access to advanced diagnostic and therapeutic products. For example, in June 2023, the University of Pittsburgh Medical Center (UPMC) partnered with PharmaLogic Holdings Corporation to co-develop and manufacture new radiopharmaceuticals at a Pittsburgh-based facility. This collaboration focuses on translating experimental radiopharmaceutical compounds into clinically available drugs, thereby broadening access and supporting faster adoption of innovative nuclear medicine therapies in underserved areas.
Understanding the Radiopharmaceuticals Market Segmentation
This market report segments the radiopharmaceuticals industry by several categories:
1) Type: Diagnostic and Therapeutic
2) Application Areas: Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Musculoskeletal, Respiratory, Nephrology, and other fields
3) End Users: Hospitals and Ambulatory Surgical Centers, Diagnostic Centers, and Cancer Research Institutes
Further detailed subcategories include:
Diagnostic radiopharmaceuticals divided into Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) agents, and therapeutic radiopharmaceuticals segmented into Alpha Emitters, Beta Emitters, and Brachytherapy applications.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitive Landscape: Leading Companies and New Entrants in the Radiopharmaceuticals Market here
News-ID: 4501521 • Views: …
More Releases from The Business Research Company
Segment Analysis and Major Growth Areas in the Seed Protein Supplements Market
The seed protein supplements market is emerging as a fast-growing sector driven by increasing consumer interest in sustainable and plant-based nutrition solutions. As people become more health-conscious and environmentally aware, this market is set to witness remarkable expansion in the coming years. Below is a detailed overview of the current market size, key players, future trends, and segmentation within this promising industry.
Rapid Expansion Forecast for the Seed Protein Supplements Market…
Top Players and Market Competition in the Sartans Industry
The sartans market is poised for consistent expansion over the coming years, driven by a combination of demographic shifts and evolving healthcare needs. As the prevalence of chronic conditions rises, the demand for effective and affordable sartans therapies continues to grow, setting the stage for notable market progress through 2030.
Projected Growth and Size of the Sartans Market by 2030
The sartans market is anticipated to reach a valuation of…
Analysis of Key Market Segments Influencing the Water-Soluble Vitamin and Minera …
The water-soluble vitamin and mineral feed supplements market is on the verge of significant expansion, driven by evolving demands within the livestock and aquaculture industries. As advancements in nutritional technology continue to evolve, this sector is poised to deliver enhanced health benefits for animals through more precise and effective supplementation. Let's explore the current market size, key players, influential trends, and segmentation that define this growing industry.
Projected Market Size and…
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Salb …
The salbutamol active pharmaceutical ingredient (API) market is poised for significant expansion over the coming years, driven by advances in pharmaceutical technology and growing demand for effective respiratory treatments. As innovations continue to improve drug delivery and production, this sector is attracting considerable attention from manufacturers and healthcare providers alike. Below is an in-depth look at the market's growth, key players, emerging trends, and detailed segmentation.
Anticipated Market Size and Growth…
More Releases for Radiopharmaceuticals
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842
This latest report researches the industry structure, sales, revenue, price and…
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…
Global Radiopharmaceuticals Market Outlook 2020
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…
